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1. Introduction 
Purified preparations of bovine adrenocortical 
mitochondrial cytochrome P450, capable of catal- 
yzing the side-chain cleavage of cholesterol have been 
obtained [1,2]. The spectral, biochemical and 
immunological characteristics of this hemoprotein 
are now known [3,4], and the multistep nature of 
this bioconversion leading through enzyme-bound 
intermediates to pregnenolone formation, established 
[5-71. 
The first step in the activation of molecular oxygen 
by cytochrome P450 involves the formation of an 
oxyferro complex [a]. Although oxyferro inter- 
mediates of a number of cytochrome P45Os have 
been described [9] no information is available about 
this form of cytochrome P450,. The development 
of subzero temperature t chniques [lo-l 31 together 
with our studies on proton activity, dielectric on- 
stants and viscosity in fluid hydroorganic media, 
enabled the stabilization and detection of inter- 
mediates in various biological reactions [14-161. 
Among these are the oxyferro species of cytochrome 
P450, from Pseudomonas putida [ 171 and the 
highly purified microsomal cytochrome P450 (LM) 
from rabbit liver [ 181. Here we describe the forma- 
tion and stabilization at low temperature of the 
oxyferro intermediate ofcytochrome P450, isolated 
from bovine adrenocortical mitochondria. 
2. Materials and methods 
Cytochrome P450, was prepared by the method 
* Present address: University of Sherbrooke Medical Center, 
Sherbrooke, Quebec, Canada 
in [2] and stored at -80°C in 50 mM potassium phos- 
phate buffer pH 7.4. The content of endogeneous 
cholesterol was estimated by gas chromatography on 
a Girdel model 300 instrument equipped with an 
OV-17 column, using 4-cholesten-3-one as an internal 
standard [7]. In addition to cholesterol (2.75 mol/mol 
P450,) we demonstrated the presence of small 
amounts (0.1-0.4 mol/mol P450,) of the oxygen- 
ated sterol intermediates, (22R)-22-hydroxycho- 
lesterol and (20R,22R)-20,22dihydroxycholesterol, 
as natural constituents of the substrate-bound form 
of cytochrome P450,, which may contribute to the 
mixed spin state (55% low spin) of the preparation 
[7,19]. The purity of the protein was determined by 
the .&4/A 280. In the glycerol-induced low spin con- 
figuration our cytochrome P450, (Feg) preparation 
gave a ratio of 0.65. SDS electrophoresis confirmed 
that the apoprotein moved as a single band. 
Spectra were recorded on an Aminco-Chance DW2 
spectrophotometer equipped with a low temperature 
thermoregulatory device [ 141. Mixed solvents for 
spectral analysis, consisting of equal volumes of 0.1 M 
Tris-acetate buffer (pH 7.5) and glycerol (GlOH), 
were thoroughly deoxygenated by sonication in 
vacua followed by purging with purified Argon for 
15 min. After addition of cytochrome P450, and a 
photoreducing system, deoxygenation was continued 
at 4°C for an extra 1 h by passing agentle stream of 
purified argon over the surface. The photochemical 
reduction system consists of 1 mM EDTA and 10 PM 
each of acridine orange and methyl viologen 1201. All 
solvents and chemicals were of the highest purity 
commercially available and used without further 
purification. 
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3. Results and discussion 
3.1. Formation of the oxyferro-cytochrome P450, 
complex 
In the presence of 50% GlOH the Fe? cytochrome 
P450, preparation (2.3 PM) was entirely ln the low 
spin configuration [21]. After deoxygenation of the 
reaction mixture was complete the cuvette was maln- 
tamed at 4°C and the ferric heme was photoreduced 
using white light. After 50 min no further spectral 
changes occurred indicating that the reduction was 
completed. The sample cuvette was rapidly cooled 
to -30°C and the oxyferro complex was formed by 
gently purging with oxygen at 30-50 ml/min for 
10 s. During these procedures no significant spectral 
or thermal perturbations of the sample occurred. 
3.2. Spectral characterisation of the oxyfevo inter- 
mediate 
Under the above experimental conditions, we 
could begin spectroscopic observations within 5 s 
of the addition of Oz. A new species, with an absorp- 
tion spectrum distinctly different from that of the 
stable ferric or ferrous form of cytochrome P450,, 
is obtained (tig.1). Its spectrum, whichis characterized 
by *max at 422 and 555 nm, remains table for 
several hours at -3O’C in water/GlOH, 1: 1 (v/v). The 
spectrum of this new species is very similar to that of 
other Feg . O2 complexes prepared under similar 
conditions [17,181. Table 1 summarizes principal E 
values for different forms of cytochrome P450, 
under various experimental conditions. The E values 
were calculated assuming a Ae~s -AebW = 9 1 mM_‘. 
cm-’ for the difference spectrum of Fe: . CO-Fe;. 
Wavelength ,n nm 
Fig.1. Absolute spectra of 2.3 NM solubilized adrenocortical 
cytochrome P450,,, in 0.1 M Tris buffer (pH 7.5)/GlOH, 1 :l 
(v/v). (---) Oxidized form of cytochrome P450scc at +4’C; 
(---) reduced form of cytochrome P450,, at -30°C; 
(- - - -) idem after oxygenation at -30°C. 
At <-15°C the oxyferro intermediate of cyto- 
chrome P450, remains table for 23 h. At -15°C 
a first transition is observed, the maximum in the 
Soret region progressively shifts to 412 nm (flg.2). 
This new spectrum also remains table for several 
hours. Towards 0°C decomposition occurs and the 
spectrum returns to that of the original Fe; complex. 
The two spectra obtained at subzero temperature 
may represent two different forms of the oxyferro 
complex of P450,, this has been suggested for the 
similar phenomena observed with microsomal P450 
[9]. Clarification of these spectral changes at - 15°C 
await further experimentation. 
Our observations confirm the existence of a cyto- 
Table 1 
Extinction coefficients (mM . cm-‘) of various forms of cytochrome P450,, 
Compounds Wavelength (nm) 
393 412 414 422 552 556 570 
Fe’+ (LS)a 121 
Fe3+ (HS)a 103 
Fes” . Sb 120+1 11 * 1 
Fe*+ . Sb 87 f 1 14* 1 
Fe’+ . SC 88 f 1 15 + 1 
Fe’+ . S-O, c 84 + 2 12+ 1 
a From [22]; 
b In GlOH-water buffer 1: 1 (v/v) at +S”C; 
c In GlOH-water buffer 1 :l (v/v) at -30°C 
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Fig.Z.Decomposition of the oxyferro-cytochrome P450,cc 
complex prepared at -3O’C: I, First step occurring at -15’C; 
II, second step occurring towards 0°C. 
chrome P450,-FeS *+ . O2 species with spectral 
properties which closely resemble those of other 
cytochrome P450 oxygen complexes. This finding 
supports the idea that all P450dependent oxygen 
activation processes involve a similar Fe*’ . O2 
intermediate. Furthermore this suggests hat the 3 
distinctly different activities exhibited by this enzyme, 
e.g., 22- and 20-hydroxylase and 20,22desmolase, 
also involve 3 consecutive but identical oxygen activ- 
ation cycles of the heme iron [6,7]. The stabilization 
of the cytochrome P450,-oxyferro complex at 
subzero temperatures a  an early step of these oxida- 
tion cycles predicts that this technique (low tempera- 
ture spectrophotometry) has great potential for 
visualising subsequent species in the oxygen activa- 
tion process. Studies to this end, using hydroperoxy- 
sterols as a combined substrate/oxygen-donor model, 
are in progress. 
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